VIDEO: Trulance yields rapid, durable response in chronic idiopathic constipation

VIDEO: Trulance yields rapid, durable response in chronic idiopathic constipation

LAS VEGAS — In this video exclusive, Eric Shah, MD, MBA, of Dartmouth-Hitchcock Health in Lebanon, New Hampshire, discussed the use of Trulance in patients with chronic idiopathic constipation.The research was presented at the ACG Annual Scientific Meeting.Shah and colleagues compared Trulance 3 mg (plecanatide, Salix Pharmaceuticals) with placebo with regard to time to first weekly response. In addition, they looked at the number of weeks that patients had a response during the trial, as well as abdominal pain and bloating response.Shah said patients who took plecanatide compared withRead More

Share on facebook
Share on twitter
Share on linkedin